Kolkata, April 8 (IANS) A three-member Spanish cancer support team visited the Prasanta Banerji Homeopath Research Foundation (PBHRF) here to study and learn the technical know-how of alternative homeopathic medicine, Banerji protocol, for treating cancer. “We are here to see the exact method of Banerji protocol and how they provide medical assistance to cancer patients here. We are interested to bring similar medical practices in Spain,” Natalia Eres, a clinical oncologist from Barcelona, told IANS.

Eres is working on a special project on cancer and homeopathy in Spain with an objective to provide support to cancer patients with complementary medicines and useful information.

She said: “We find it a very effective mode of cancer treatment without the use of chemotherapy. In Spain, the homeopathy treatment is gradually becoming popular and we want to disseminate knowledge of Banerji protocol not only in Spain but amongst the entire Spanish-speaking population.”

During the six-day visit to the city that concluded Monday, the team of clinical oncologists interacted with patients at PBHRF and saw the alternative method of treating cancer.

Well-known homeopaths Prasanta Banerji, founder and managing trustee, and his son Pratip Banerji are the principal doctors of the foundation. It is the only homeopathic research organisation in India accredited by the Department of Scientific and Industrial Research (DSIR).

The foundation has become popular due to path-breaking treatment for cancer and other chronic diseases by the use of ‘The Banerji Protocol’ - an alternative mode of treatment using homeopathic medicines.

“We are also trying to popularise this alternative treatment through an online web portal, www.ayudacancer.com,” said Asuncion Pastor Caurtero of Valencia who runs the Spanish web portal to help cancer patients across the globe.

“We are already associated with the University of Texas MD Anderson Cancer Centre at Houston, cancer research unit of University of Kansas and with Columbia University for the treatment of paediatric cancer,” said Pratip Banerji.

“We are interested in similar practices in future also. Spanish is the second largely-spoken language in the world and if we can be present there it would help us to penetrate a large section of people in Spain as well as in many Latin American countries,” he said.

This year, both Prasanta and Pratip Banerji have been included in the International Scientific Advisory Committee of the first international Virtual Congress of Biological and Natural Medicine in Spain.